Price to Earnings of Kobayashi Pharmaceut

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Price to Earnings analysis of Kobayashi Pharmaceut


 Price 7,800.00  JPY
 Earnings per share 229.41  JPY
 Capitalization (mn) 477,693  JPY
 Net income (mn) 18,123  JPY
 P/E ratio 34.00
 Kobayashi Pharmaceut dividend
 Kobayashi Pharmaceut Price to book Value
 Kobayashi Pharmaceut Price to Cash-Flow
 Kobayashi Pharmaceut Return on Equity

Kobayashi Pharmaceut is a Health Care industry firm, which concentrates their activity in the Pharmaceuticals and Biotechnology sector. Kobayashi Pharmaceut headquarters are in Japan, where the firm is listed.

At the time of this analysis, Kobayashi Pharmaceut stocks were trading at a price of 7,800.00 JPY after climbing a 1.20% last month.

According to the chart displayed below, Kobayashi Pharmaceut Price to Earnings Ratio is 34.00, bigger than the amount offered by both firms from Japan and fromPharmaceuticals and Biotechnology sector. This high P/E might be a sign of a overvalued company, but also a healthy sign because the market expects growing earnings in the future.Therefore, it is necessary to study Kobayashi Pharmaceut financial situation to reach a conclussion.

Finally, you could compare Kobayashi Pharmaceut P/E with other Pharmaceuticals and Biotechnology companies or firms from Japan.

Kobayashi Pharmaceut price to earnings

Next companies

Kobe Steel. Japan. Basic Materials.

KOC Holdings A.S. Turkey. Oil and Gas.

Kohl's Corp. USA. Consumer Services.

Koito Manufacturing. Japan. Consumer Goods.

Kokuyo. Japan. Consumer Goods.

Komatsu. Japan. Industrials.

Previous companies

Knorr-Bremse. Germany. Industrials.

Klepierre. France. Financials.

KLCC PROP & KLCC REI. Malaysia. Financials.

Klabin SA. Brazil. Industrials.

Kla-Tencor Corp. USA. Technology.

Kiwi Property Group. New Zealand. Financials.

All rights reserved

 information advertisement legal

Dividends Ranking | Price to BookValue | Price to Cash-Flow | Price to Earnings | Return on Equity

Part of Enciclopedia Financiera Group

Disclaimer: Information on this site is only for informational purposes. Always consult a professional advisor before investing.